MEENAKSHI HEGDE

Concepts (182)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Immunotherapy, Adoptive
12
2025
888
2.440
Why?
T-Lymphocytes
16
2025
1814
2.180
Why?
Receptor, ErbB-2
9
2025
559
2.090
Why?
Glioblastoma
8
2018
374
1.480
Why?
Sarcoma
3
2025
209
1.030
Why?
Immunotherapy
7
2021
746
0.990
Why?
Interleukin-13 Receptor alpha2 Subunit
4
2018
20
0.880
Why?
Antigens, Neoplasm
4
2020
407
0.860
Why?
Receptors, Antigen, T-Cell
8
2020
503
0.840
Why?
Brain Neoplasms
7
2020
1407
0.810
Why?
Muscle Neoplasms
1
2020
21
0.680
Why?
Neoplasm Recurrence, Local
3
2025
1313
0.650
Why?
Cancer Vaccines
3
2020
190
0.640
Why?
Tumor Escape
2
2016
65
0.610
Why?
Rhabdomyosarcoma
1
2020
209
0.550
Why?
Cell- and Tissue-Based Therapy
2
2017
170
0.530
Why?
Adoptive Transfer
2
2014
241
0.480
Why?
Central Nervous System Neoplasms
1
2014
216
0.360
Why?
Cell Line, Tumor
6
2025
3751
0.360
Why?
Hematopoietic Stem Cell Transplantation
4
2023
1188
0.350
Why?
Hematologic Neoplasms
2
2025
294
0.340
Why?
Lymphocyte Activation
2
2025
724
0.310
Why?
Neoplasms
4
2025
3025
0.290
Why?
Antibodies, Monoclonal
1
2014
1068
0.290
Why?
Xenograft Model Antitumor Assays
7
2025
1006
0.280
Why?
Lymphocyte Depletion
2
2024
125
0.270
Why?
Transplantation Conditioning
2
2018
300
0.250
Why?
Endoglin
1
2025
30
0.240
Why?
Mice, SCID
3
2018
613
0.240
Why?
B7 Antigens
1
2025
14
0.240
Why?
Cyclophosphamide
2
2024
417
0.230
Why?
Antibodies, Bispecific
1
2025
51
0.230
Why?
Immunological Synapses
1
2025
29
0.230
Why?
Membrane Microdomains
1
2025
63
0.220
Why?
Humans
31
2025
133414
0.220
Why?
Vidarabine
1
2024
78
0.220
Why?
Molecular Dynamics Simulation
1
2025
116
0.220
Why?
Programmed Cell Death 1 Receptor
1
2025
129
0.220
Why?
B7-H1 Antigen
1
2025
129
0.220
Why?
Mice
9
2025
18911
0.210
Why?
Cord Blood Stem Cell Transplantation
1
2023
46
0.200
Why?
Antigens, CD19
2
2021
181
0.190
Why?
Tumor Cells, Cultured
4
2020
1102
0.190
Why?
Leukocytes, Mononuclear
3
2022
358
0.190
Why?
Antibodies, Monoclonal, Humanized
1
2025
551
0.180
Why?
Leukemia
1
2024
380
0.180
Why?
Treatment Outcome
6
2024
12974
0.170
Why?
Lymphoma
1
2024
335
0.170
Why?
Child
14
2025
25734
0.170
Why?
Clinical Trials, Phase I as Topic
1
2020
66
0.170
Why?
Leukemia, B-Cell
1
2020
26
0.170
Why?
Animals
10
2025
36379
0.170
Why?
Cerebrospinal Fluid
1
2020
99
0.160
Why?
Transplantation, Autologous
1
2020
285
0.160
Why?
Immunologic Memory
1
2021
199
0.160
Why?
Remission Induction
1
2020
307
0.160
Why?
Transgenes
2
2020
346
0.150
Why?
Osteosarcoma
2
2019
263
0.150
Why?
Bone Marrow
1
2020
335
0.150
Why?
Receptor, EphA2
1
2018
29
0.150
Why?
Ependymoma
1
2020
175
0.150
Why?
Epigenomics
1
2019
195
0.140
Why?
Antigenic Variation
1
2018
42
0.140
Why?
Wiskott-Aldrich Syndrome
1
2017
23
0.140
Why?
Alemtuzumab
1
2018
88
0.140
Why?
Granulomatous Disease, Chronic
1
2018
69
0.140
Why?
Male
13
2025
65692
0.130
Why?
Biopsy
1
2020
1300
0.130
Why?
Transplantation, Homologous
1
2018
692
0.130
Why?
Protein Binding
2
2020
1833
0.130
Why?
Interleukin-13
1
2016
101
0.130
Why?
Prospective Studies
2
2024
6570
0.120
Why?
Protein Multimerization
1
2016
144
0.120
Why?
Neoplasm Transplantation
1
2016
399
0.120
Why?
HEK293 Cells
2
2020
813
0.120
Why?
Autoimmune Diseases
1
2018
276
0.120
Why?
Flow Cytometry
2
2015
836
0.120
Why?
Microspheres
1
2015
75
0.120
Why?
Receptors, Cell Surface
1
2017
497
0.120
Why?
Immediate-Early Proteins
1
2015
60
0.120
Why?
Viral Matrix Proteins
1
2015
110
0.120
Why?
Medulloblastoma
1
2020
570
0.120
Why?
Head and Neck Neoplasms
1
2021
699
0.120
Why?
Female
14
2025
71463
0.120
Why?
Carcinoma, Squamous Cell
1
2021
872
0.110
Why?
Child, Preschool
8
2025
14789
0.110
Why?
Immunophenotyping
1
2015
342
0.110
Why?
Triple Negative Breast Neoplasms
1
2017
267
0.110
Why?
Follow-Up Studies
5
2025
5455
0.110
Why?
Adenocarcinoma
1
2021
1070
0.110
Why?
Adolescent
9
2025
20505
0.100
Why?
Neoplasm Proteins
1
2017
716
0.100
Why?
Adult
7
2024
31787
0.100
Why?
Phosphoproteins
1
2015
456
0.100
Why?
Cardiovascular Diseases
1
2025
2087
0.090
Why?
Cytotoxicity, Immunologic
2
2025
277
0.090
Why?
Aged
4
2024
21609
0.090
Why?
Maximum Tolerated Dose
2
2025
173
0.090
Why?
Genomics
1
2019
1672
0.090
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2018
809
0.090
Why?
Infant
6
2025
13159
0.090
Why?
Recombinant Fusion Proteins
1
2013
801
0.080
Why?
Bone Neoplasms
1
2015
446
0.080
Why?
Antigens, Viral
1
2012
440
0.080
Why?
Middle Aged
4
2024
29213
0.080
Why?
Combined Modality Therapy
1
2013
1306
0.080
Why?
Cytomegalovirus
3
2017
270
0.080
Why?
Models, Biological
1
2013
1532
0.070
Why?
Retrospective Studies
5
2025
17380
0.070
Why?
Lung Neoplasms
1
2017
1787
0.070
Why?
Antineoplastic Agents
1
2016
1850
0.060
Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
1
2025
26
0.060
Why?
Neoplasm Metastasis
2
2020
745
0.060
Why?
Pediatrics
1
2014
1216
0.060
Why?
CD28 Antigens
1
2025
81
0.060
Why?
Young Adult
3
2025
9854
0.050
Why?
Busulfan
1
2023
45
0.050
Why?
Neutropenia
1
2024
201
0.050
Why?
Survival Rate
2
2017
2210
0.050
Why?
Thrombocytopenia
1
2024
236
0.050
Why?
Prognosis
2
2025
5074
0.050
Why?
Dose-Response Relationship, Drug
1
2025
1734
0.050
Why?
Apoptosis
2
2018
1928
0.040
Why?
Injections, Intraventricular
1
2020
65
0.040
Why?
Cell Proliferation
2
2018
2548
0.040
Why?
Immunity, Cellular
1
2021
217
0.040
Why?
T-Lymphocyte Subsets
1
2021
215
0.040
Why?
Treatment Failure
1
2021
364
0.040
Why?
Transduction, Genetic
1
2020
296
0.040
Why?
Structure-Activity Relationship
1
2020
610
0.040
Why?
Drug Delivery Systems
1
2020
232
0.040
Why?
Gene Editing
1
2021
212
0.040
Why?
CD8-Positive T-Lymphocytes
1
2021
445
0.040
Why?
Chimerism
1
2018
29
0.040
Why?
Guillain-Barre Syndrome
1
2018
31
0.040
Why?
Pancytopenia
1
2018
42
0.040
Why?
Unrelated Donors
1
2018
70
0.040
Why?
Mice, Inbred NOD
1
2018
318
0.030
Why?
Allografts
1
2017
198
0.030
Why?
History, 21st Century
1
2018
275
0.030
Why?
Clinical Trials as Topic
1
2021
1154
0.030
Why?
Mutation
2
2021
6290
0.030
Why?
Cerebellar Neoplasms
1
2020
461
0.030
Why?
Polystyrenes
1
2015
12
0.030
Why?
Microfilament Proteins
1
2017
289
0.030
Why?
Infant, Newborn
2
2019
8586
0.030
Why?
Color
1
2015
34
0.030
Why?
Neuroectodermal Tumors
1
2015
13
0.030
Why?
Disease-Free Survival
1
2017
971
0.030
Why?
Gene Expression
1
2020
1614
0.030
Why?
Proteomics
1
2019
595
0.030
Why?
Tumor Suppressor Protein p53
1
2019
791
0.030
Why?
Interleukin-13 Receptor alpha1 Subunit
1
2014
6
0.030
Why?
Adenoviridae
1
2017
610
0.030
Why?
Immunotoxins
1
2014
21
0.030
Why?
Herpesvirus 4, Human
1
2017
675
0.030
Why?
Mice, Transgenic
1
2020
2526
0.030
Why?
Leukocytes
1
2015
223
0.030
Why?
Fluorescent Dyes
1
2015
270
0.030
Why?
Sarcoma, Ewing
1
2015
116
0.030
Why?
Antibodies
1
2015
382
0.030
Why?
Cytokines
1
2020
1393
0.030
Why?
Positron-Emission Tomography
1
2015
310
0.030
Why?
Amino Acid Substitution
1
2014
412
0.030
Why?
Signal Transduction
1
2025
4897
0.020
Why?
Kaplan-Meier Estimate
1
2015
1139
0.020
Why?
Cell Separation
1
2012
234
0.020
Why?
Recurrence
1
2015
1464
0.020
Why?
In Situ Hybridization
1
2012
484
0.020
Why?
Recombinant Proteins
1
2014
1437
0.020
Why?
Case-Control Studies
1
2017
3642
0.020
Why?
Biomarkers
1
2020
3424
0.020
Why?
Incidence
1
2018
3396
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
866
0.020
Why?
Cytomegalovirus Infections
1
2012
228
0.020
Why?
Biomarkers, Tumor
1
2017
1717
0.020
Why?
Disease Models, Animal
1
2020
4779
0.020
Why?
Tomography, X-Ray Computed
1
2015
2172
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2014
2120
0.020
Why?
Cohort Studies
1
2015
5176
0.020
Why?
Magnetic Resonance Imaging
1
2015
3840
0.010
Why?
Risk Factors
1
2017
11085
0.010
Why?
HEGDE's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (182)
Explore
_
Co-Authors (71)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_